246710.KQ
T&R Biofab Co., Ltd.
KOE · Healthcare · Medical - Specialties · KR
KRW 1,877.00
−1.52%Year over year
Reported trailing growth
- Revenue
- +120.9%
- EBITDA
- +39.9%
- EBIT
- +49.5%
- EPS
- -62.9%
- Free cash flow
- +65.5%
- Operating cash flow
- +81.0%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +67.3%
- EBITDA
- -33.5%
- EBIT
- +9.2%
- Net income
- —
- EPS
- —
- Free cash flow
- +33.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026